Literature DB >> 22544745

The MUC1-C oncoprotein binds to the BH3 domain of the pro-apoptotic BAX protein and blocks BAX function.

Rehan Ahmad1, Maroof Alam, Hasan Rajabi, Donald Kufe.   

Abstract

The pro-apoptotic BAX protein contains a BH3 domain that is necessary for its dimerization and for activation of the intrinsic apoptotic pathway. The MUC1 (mucin 1) heterodimeric protein is overexpressed in diverse human carcinomas and blocks apoptosis in the response to stress. In this study, we demonstrate that the oncogenic MUC1-C subunit associates with BAX in human cancer cells. MUC1-C·BAX complexes are detectable in the cytoplasm and mitochondria and are induced by genotoxic and oxidative stress. The association between MUC1-C and BAX is supported by the demonstration that the MUC1-C cytoplasmic domain is sufficient for the interaction with BAX. The results further show that the MUC1-C cytoplasmic domain CQC motif binds directly to the BAX BH3 domain at Cys-62. Consistent with binding to the BAX BH3 domain, MUC1-C blocked BAX dimerization in response to (i) truncated BID in vitro and (ii) treatment of cancer cells with DNA-damaging agents. In concert with these results, MUC1-C attenuated localization of BAX to mitochondria and the release of cytochrome c. These findings indicate that the MUC1-C oncoprotein binds directly to the BAX BH3 domain and thereby blocks BAX function in activating the mitochondrial death pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544745      PMCID: PMC3375510          DOI: 10.1074/jbc.M112.357293

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Oxidative Bax dimerization promotes its translocation to mitochondria independently of apoptosis.

Authors:  M D'Alessio; M De Nicola; S Coppola; G Gualandi; L Pugliese; C Cerella; S Cristofanon; P Civitareale; M R Ciriolo; A Bergamaschi; A Magrini; L Ghibelli
Journal:  FASEB J       Date:  2005-06-21       Impact factor: 5.191

2.  Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.

Authors:  Xiaolong Wei; Hai Xu; Donald Kufe
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

3.  Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.

Authors:  K Wang; A Gross; G Waksman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

4.  Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations.

Authors:  Y T Hsu; R J Youle
Journal:  J Biol Chem       Date:  1998-04-24       Impact factor: 5.157

5.  Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Authors:  J Zha; H Harada; E Yang; J Jockel; S J Korsmeyer
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

6.  Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak.

Authors:  Dayong Zhai; Frederic Luciano; Xiuwen Zhu; Bin Guo; Arnold C Satterthwait; John C Reed
Journal:  J Biol Chem       Date:  2005-01-20       Impact factor: 5.157

7.  MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress.

Authors:  Li Yin; Lei Huang; Donald Kufe
Journal:  J Biol Chem       Date:  2004-08-18       Impact factor: 5.157

8.  Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin.

Authors:  Y Li; A Bharti; D Chen; J Gong; D Kufe
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

9.  Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis.

Authors:  A Gross; J Jockel; M C Wei; S J Korsmeyer
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

10.  Movement of Bax from the cytosol to mitochondria during apoptosis.

Authors:  K G Wolter; Y T Hsu; C L Smith; A Nechushtan; X G Xi; R J Youle
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

View more
  24 in total

Review 1.  Cellular and molecular biology of airway mucins.

Authors:  Erik P Lillehoj; Kosuke Kato; Wenju Lu; Kwang C Kim
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

2.  Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor-Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis.

Authors:  Taylor E Escher; Asona J Lui; Eric S Geanes; Katherine R Walter; Ossama Tawfik; Christy R Hagan; Joan Lewis-Wambi
Journal:  Mol Cancer Res       Date:  2019-01-17       Impact factor: 5.852

3.  Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.

Authors:  Tsuyoshi Hata; Hasan Rajabi; Masaaki Yamamoto; Caining Jin; Rehan Ahmad; Yan Zhang; Ling Kui; Wei Li; Yota Yasumizu; Deli Hong; Masaaki Miyo; Masayuki Hiraki; Takahiro Maeda; Yozo Suzuki; Hidekazu Takahashi; Mehmet Samur; Donald Kufe
Journal:  Mol Cancer Ther       Date:  2019-07-15       Impact factor: 6.261

Review 4.  MUC1 in hematological malignancies.

Authors:  Dina Stroopinsky; Donald Kufe; David Avigan
Journal:  Leuk Lymphoma       Date:  2016-06-27

5.  Inhibition of the MUC1-C oncoprotein is synergistic with cytotoxic agents in the treatment of breast cancer cells.

Authors:  Yasumitsu Uchida; Deepak Raina; Surender Kharbanda; Donald Kufe
Journal:  Cancer Biol Ther       Date:  2012-10-31       Impact factor: 4.742

Review 6.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

Review 7.  Protein mislocalization: mechanisms, functions and clinical applications in cancer.

Authors:  Xiaohong Wang; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-04-04

8.  Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells.

Authors:  Yosuke Harazono; Dhong Hyo Kho; Vitaly Balan; Kosei Nakajima; Tianpeng Zhang; Victor Hogan; Avraham Raz
Journal:  Oncotarget       Date:  2014-10-30

9.  Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.

Authors:  Danye Zhang; Jian Gao; Liancheng Zhu; Zhenhua Hu; Rui Hou; Shuice Liu; Mingzi Tan; Juanjuan Liu; Bei Lin
Journal:  Int J Mol Sci       Date:  2013-05-24       Impact factor: 5.923

10.  MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors.

Authors:  Masayuki Hiraki; Yozo Suzuki; Maroof Alam; Kunihiko Hinohara; Masanori Hasegawa; Caining Jin; Surender Kharbanda; Donald Kufe
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.